The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses

Clinical and Experimental Immunology

Volumn 113, Issue 2, 1998, Pages 235-243

  Hu, K F ^a,d   Elvander, M ^b   Merza, M ^b   Akerblom L ^b   Brandenburg, A ^c   Morein, B ^a,b  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b NATIONAL VETERINARY INSTITUTE   (Sweden)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d Biomedicum ^*  (Sweden)

Author keywords

ISCOMs; Mucosal immunity; Respiratory syncytial virus; Vaccine

Indexed keywords

ENVELOPE PROTEIN; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; DRUG DELIVERY SYSTEM; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSTIMULATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS ENVELOPE;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; DRUG DELIVERY SYSTEMS; FEMALE; HN PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INJECTIONS, SUBCUTANEOUS; ISCOMS; LUNG; MICE; MICE, INBRED BALB C; MUCOUS MEMBRANE; NASAL MUCOSA; NEUTRALIZATION TESTS; RESPIRATORY SYNCYTIAL VIRUSES; RESPIRATORY SYSTEM; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRAL VACCINES;

EID: 0031902954     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00650.x     Document Type: Article

References (35)

1. McIntosh K, Chanock RM. Respiratory syncytial virus. In: Fields BN, ed. Virology. New York: Raven Press, 1990:1045-72.
2. Heilman CA. Respiratory syncytial and parainfluenza viruses. J Infect Dis 1990; 161:402-6.
3. Heilman CA. Respiratory syncytial and parainfluenza viruses. J Infect Dis 1990; 161:402-6.
4. Trudel M, Nadon F, Seguin C, Brault S, Lusignan Y, Lemieus S. Induction of cytotoxic T-cell response and protection of BALB/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine. Vaccine 1992; 10:107-12.
5. Murphy BR, Sotnikov A, Paradiso PR et al. Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease. Vaccine 1989; 7:533-40.
6. Holmgren J, Czerkinsky C, Lycke N, Svennerholm AM. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carries and adjuvant. Am J Trop Med Hyg 1994; 50 (Suppl.):42-54.
7. Morein B, Sundquist B, Dalsgaard K, Osterhaus A. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 1984; 308:457-69.
8. Morein B, Lövgren K, Sundquist B. Iscom - an immunostimulating complex. Immunol Today 1987; 11:333-8.
9. Morein B, Lövgren K, Rönnberg B, Sjölander A, Villacres-Eriksson M. Immunostimulating complexes, clinical potential in vaccine development. Clin Immunother 1995; 3:461-75.
10. Trudel M, Nadon F, Seguin C, Simard C, Lussier G. Experimental polyvalent ISCOMs subunit vaccine induces antibodies that neutralize human and bovine respiratory syncytial virus. Vaccine 1989; 7:12-16.
11. Lövgren K, Lindmark J, Pipkorn R, Morein B. Antigenic presentation of small molecules and peptides conjugated to a preformed iscom as carrier. J Immunol Methods 1989; 98:137-43.
12. Morein B, Sharp M, Sundquist B, Simons K. Protein subunit vaccines of parainfluenza type 3 virus: immunogenic effect in lambs and mice. J G Virol 1983; 4:1557-69.
13. Sundquist B, Lövgren K, Hoglund S, Morein B. Influenza virus iscoms: biochemical characterization. Vaccine 1988; 6:44-58.
14. Bradford MM. A rapid and sensitive method for the quantificaton of microgram quantities of protein untilizing the principle of protein-dye binding. Anal Biochem 1976; 72:249-54.
15. Rönnberg B, Fekadu M, Morein B. Adjuvant activity of non-toxic quillaja saponaria Molina components for use in ISCOM matrix. Vaccine 1995; 13:1375-82.
16. Bergquist C, Lagergxrd T, Lindblad M, Holmgren J. Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates. Infect Immun 1995; 63:2021-5.
17. Jennings R, Auasim T, Sharrard TM, Hockley D, Potter CW. Zwitterionic detergent solubilisation of HSV-1-specific surface antigens. Arch Virol 1988; 98:137-53.
18. Jennings R, Smith T, Potter CW. Use of enzyme-linked immunosorbent assay (ELISA) for the estimation of serum antibodies in an influenza virus vaccine study. Med Microbiol Immunol 1981; 169:247-58.
19. Hocart MJ, Mackenzie JS, Stewart GA. The IgG subclass responses induced by wild-type, cold-adapted and purified haemagglutinin from influenza virus A/Queensland/6/72 in CBA/CaH mice. J Gen Virol 1988; 69:1873-82.
20. Towbin H, Staehelin T, Gordin J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4.
21. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg 1938; 27:493-7.
22. Walker RI. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 1994; 12:387-400.
23. Ogra PL, Strober W, Mestecky J, McGhee JR, Lamm ME, Bienenstock J. Handbook of mucosal immunology. San Diego: Academic Press, 1994:339.
24. Höglund S, Dalegaard K, Lögren K, Sundquist B, Osterhaus A, Morein B. ISCOMs and immunostimulation with viral antigens. Subcellular Biochem 1989; 15:39-67.
25. van Binnendijk RS, Poelen MC, van Amerongen G, de Vries P, Osterhaus AD. Protective immunity in macaques vaccinated with live attenuated recombinant and subunit measles vaccine in the presence of passively acquired antibodies. J Infect Dis 1997; 175:524-32.
26. Forsthuber T, Yip HC, Lehnmann PV. Induction of Th1 and Th2 immunity in neonatal mice. Science 1996; 271:1728-30.
27. Adkins B, Chun K, Hamilton K, Nassire M. Naive murine neonatal T cells undergo apoptosis in response to primary stimulation. J Immunol 1996; 157:1343-9.
28. Nordengrahn A, Rusvai M, Merza M, Ekström J, Morein B, Belák S. Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunostimulating complexes. Vet Microbil 1996; 51:55-68.
29. Lövgren K. The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes. Scand J Immunol 1988; 27:241-5.
30. Yetter RA, Lehrer S, Ramphal R, Small JPA. Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infect Immun 1980; 29:654-62.
31. Morein B, Lövgren K, Rönnberg B, Sjölander A, Villacrés-Eriksson M. Immunostimulating complexes: clinical potential in vaccine development. Clin Immunother 1995; 3:461-75.
32. + T cell responses by oral or parenteral immunization with ISCOMs. Eur J Immunol 1995; 25:2835-41.
33. Ogra PL, Strober W, Mestecky J, McGhee JR, Lamm ME, Bienestock J. Handbook of mucosal immunology. San Diego: Academic Press, 1994:625-40.
34. Brandtzaeg P. The role of humoral mucosal immunity in the induction and maintenance of chronic airway infections. Am J Respir Crit Care Med 1995; 151:2081-7.
35. Rosenthal KL, Gallichan WS. Challenges for vaccination against sexually transmitted diseases: induction and long-term maintenance of mucosal immune responses in the female genital tract. Sem Immunol 1997; 9:303-14.